PipelineReview.com2d
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
November 04, 2024 I Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...
Medscape3d
Bimekizumab Offers Durable and Consistent Benefits in HS
AMSTERDAM — The monoclonal antibody bimekizumab (Bimzelx ... over time with the first FDA-approved class of biologics for ...